Warning: simplexml_load_string(): Entity: line 39: parser error : Input is not proper UTF-8, indicate encoding ! Bytes: 0xC2 0x26 0x23 0x38 in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): d time-consuming. So why not bring the doctor to the patient - digitally?     in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): ^ in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: Invalid argument supplied for foreach() in /mnt/ebs/scidaily/public_html/video.php on line 919 Warning: DOMNode::appendChild(): Document Fragment is empty in /mnt/ebs/scidaily/public_html/video.php on line 497 NH Worker Gets 39 Yrs in Hepatitis Case -- ScienceDaily

Science Videos

from AP, Reuters, AFP, and other news services

NH Worker Gets 39 Yrs in Hepatitis Case

Date:
December 2, 2013
Source:
AP / Powered by NewsLook.com
Summary:
A traveling medical technician who stole painkillers and infected dozens of patients in multiple states with hepatitis C through tainted syringes was sentenced Monday to 39 years in prison. (Dec. 2)


Related Videos

last updated on 2014-07-31 at 3:51 am EDT

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
First U.S. Patient of Deadly MERS Virus Responding to Treatment

First U.S. Patient of Deadly MERS Virus Responding to Treatment

Reuters - US Online Video (May 5, 2014) — A healthcare worker being treated in Indiana with the first U.S. case of the often fatal Middle East Respiratory Syndrome (MERS) is in good condition and improving daily, the state health department says. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Second U.S. Case Of MERS Virus Discovered

Second U.S. Case Of MERS Virus Discovered

Newsy (May 12, 2014) — A second U.S. MERS case was confirmed Monday. The patient is a Florida health care worker believed to have treated MERS patients in Saudi Arabia. Video provided by Newsy
Powered by NewsLook.com
New Vaccine Brings Hope for Hepatitis B Eradication

New Vaccine Brings Hope for Hepatitis B Eradication

Reuters (Aug. 5, 2013) — Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to stop the disease in its tracks and is currently seeking approval for its use in the United States and Europe.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins